1-5 of 5
acitretin
Close
Sort by
Journal Articles

Acitretin Reduces L-Selectin Expression and Tumour Cell Homing in Chronic Lymphocytic Leukaemia (CLL)

Saad Ahmed, MBBS, Mattia Cremona, PhD, Sinead Toomey, PhD, Mark Catherwood, PhD, Stephen Bergin, BS, Paul Kennedy, BS, Bryan Hennessy, MD, Patrick Thornton, MB, FRCPath, John Quinn, MD PhD, Philip Murphy, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5532.
https://doi.org/10.1182/blood-2018-99-114104
Published: 2018
Journal Articles

Strong Correlation Between CTLA-4 and LEF1 Gene Expression Levels in CLL: Targeting of the Wnt/β-Catenin Pathway May Adversely Affect CTLA-4 Expression and Function

Philip T Murphy, MD, Gary Lynch, Stephen Bergin, John Quinn, MD PhD, Siobhan Glavey, MD, Philip W Murphy, Paul Kennedy
Journal: Blood
Blood (2016) 128 (22): 5571.
https://doi.org/10.1182/blood.V128.22.5571.5571
Published: 2016
Journal Articles

The Retinoid Derivative Drug, Acitretin, Modulates CD38 Expression on MEC-1 Cells and Primary Chronic Lymphocytic Leukemia (CLL) Cells and Reduces Migration in Response to the Chemokine CXCL12

Sally Elsir Mohammed, MBBS, MRCP(UK), Philip Murphy, MD, John Quinn, Patrick Thornton, FRCPath, Stephen Bergin, Bryan Hennessy
Journal: Blood
Blood (2015) 126 (23): 5271.
https://doi.org/10.1182/blood.V126.23.5271.5271
Published: 2015
Journal Articles

Erratum for vol. 92, p. 3578

Journal: Blood
Blood (1999) 93 (8): 2753.
https://doi.org/10.1182/blood.V93.8.2753a
Published: 1999
Journal Articles

Prospective Randomized Multicenter Clinical Trial on the Use of Interferon -2a Plus Acitretin Versus Interferon -2a Plus PUVA in Patients With Cutaneous T-Cell Lymphoma Stages I and II

R. Stadler, H.-G. Otte, T. Luger, B.M. Henz, P. Kühl, T. Zwingers, W. Sterry
Journal: Blood
Blood (1998) 92 (10): 3578–3581.
https://doi.org/10.1182/blood.V92.10.3578
Published: 1998